Related Experiment Video
Updated: May 30, 2026

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
Toward an integrated knowledge environment to support modern oncology.
Patrick M Blake1, David A Decker, Timothy M Glennon
1Sophic Systems Alliance Inc, East Falmouth, MA 02536, USA. pat@sophicalliance.com.
Oncology informatics is evolving from siloed systems to integrated knowledge environments. This integration aims to connect research data with patient clinical information for improved cancer discovery and care.
Area of Science:
- Bioinformatics
- Cancer Research
- Health Informatics
Background:
- Diverse data types (genomics, clinical outcomes, drug info) are collected globally.
- Current data systems are fragmented, hindering the connection between research and clinical information.
- Manual data curation and annotation are resource-intensive.
Purpose of the Study:
- To review progress in developing integrated knowledge environments for oncology.
- To highlight the shift from siloed systems to connected platforms.
- To focus on enhancing scientific discovery and patient care in oncology.
Main Methods:
- Review of current oncology informatics systems and data integration strategies.
- Analysis of challenges in connecting disparate research and clinical datasets.
- Exploration of approaches to create unified knowledge environments.
Main Results:
- Significant efforts are underway to capture and analyze complex cancer-related data.
- The need for integrated systems that bridge research and clinical data is increasingly recognized.
- Progress is being made towards creating environments that link diverse data sources.
Conclusions:
- Integrating scattered databases is crucial for advancing cancer research and treatment.
- The evolution towards integrated knowledge environments promises to accelerate scientific discovery.
- Improved data connectivity will ultimately support better patient outcomes in oncology.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

